Search

everythinglearnresearchcommunity

for

Search:↓

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

The US Military supports transgender health care, but many needed skin procedures aren't covered by insurance.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Men had worse COVID-19 outcomes than women in New York City.

The healthcare for transgender veterans could be better with a more unified team approach.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Genetic mutations can affect female sexual development, requiring personalized medical care.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Research on transgender men needs clearer theories to improve understanding and decision-making.

Facial hair is crucial for gender affirmation, but many face financial barriers to achieving desired results.

Finasteride affects offspring's antioxidant enzymes in epididymis, possibly disrupting sperm maturation.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.